Stock TNDM TANDEM DIABETES CARE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Tandem Diabetes Care, Inc.

Equities

TNDM

US8753722037

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq
Other stock markets
 21:30:00 03/05/2024 BST 		5-day change 1st Jan Change
44.72 USD +22.32% Intraday chart for Tandem Diabetes Care, Inc. +26.90% +51.18%
05-03 Sector Update: Health Care Stocks Mixed in Afternoon Trading MT
05-03 Tandem Diabetes Care Shares Rise After Q1 Net Loss Shrinks, Sales Rise; Q2, 2024 Sales Guidance Set MT

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 3,523 5,951 9,563 2,890 1,929 2,887 - -
Enterprise Value (EV) 1 3,346 6,059 9,221 2,890 1,746 2,743 2,776 2,791
P/E ratio -142 x -171 x 627 x -30.6 x -8.62 x -27.3 x -45.1 x -75.3 x
Yield - - - - - - - -
Capitalization / Revenue 9.72 x 11.9 x 13.6 x 3.61 x 2.58 x 3.34 x 3.03 x 2.77 x
EV / Revenue 9.24 x 12.1 x 13.1 x 3.61 x 2.34 x 3.17 x 2.91 x 2.67 x
EV / EBITDA -314 x 2,429 x 253 x 54.1 x -190 x 907 x 68.8 x 40.1 x
EV / FCF 150 x -2,212 x 94.9 x - -29.8 x -114 x 209 x 44.6 x
FCF Yield 0.67% -0.05% 1.05% - -3.36% -0.88% 0.48% 2.24%
Price to Book 17.9 x 15.9 x 22.4 x - 6.13 x 9.63 x 9.23 x 8.39 x
Nbr of stocks (in thousands) 59,093 62,195 63,533 64,299 65,210 64,563 - -
Reference price 2 59.61 95.68 150.5 44.95 29.58 44.72 44.72 44.72
Announcement Date 24/02/20 24/02/21 22/02/22 22/02/23 21/02/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 362.3 498.8 702.8 801.2 747.7 864.6 952.6 1,044
EBITDA 1 -10.65 2.494 36.5 53.41 -9.191 3.025 40.35 69.69
EBIT 1 -16.72 -7.957 22.65 -45.84 -112.6 -116.1 -83.37 -59.88
Operating Margin -4.62% -1.6% 3.22% -5.72% -15.06% -13.43% -8.75% -5.74%
Earnings before Tax (EBT) 1 -24.6 -36.28 15.9 -92.85 -220.3 -116.4 -74.42 -38.47
Net income 1 -24.75 -34.38 15.57 -94.59 -222.6 -112.1 -75.97 -44.15
Net margin -6.83% -6.89% 2.21% -11.81% -29.77% -12.96% -7.97% -4.23%
EPS 2 -0.4200 -0.5600 0.2400 -1.470 -3.430 -1.635 -0.9907 -0.5941
Free Cash Flow 1 22.36 -2.739 97.18 - -58.61 -24.02 13.28 62.54
FCF margin 6.17% -0.55% 13.83% - -7.84% -2.78% 1.39% 5.99%
FCF Conversion (EBITDA) - - 266.26% - - - 32.91% 89.75%
FCF Conversion (Net income) - - 624.3% - - - - -
Dividend per Share 2 - - - - - - - -
Announcement Date 24/02/20 24/02/21 22/02/22 22/02/23 21/02/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 179.6 210 175.9 200.3 205.1 220.5 169.4 195.9 185.6 196.8 191.7 206.3 220.9 251.7 217.7
EBITDA 1 11.12 16.26 6.4 11.44 9.866 25.7 -20.16 5.265 1.455 4.252 -14.45 -2.807 9.114 16.03 -
EBIT 1 7.72 12.74 -15.34 -12.24 -15.88 -2.385 -127.8 -38.81 -23.31 -22.52 -40.53 -38.8 -24.28 -14.15 -27.08
Operating Margin 4.3% 6.07% -8.72% -6.11% -7.74% -1.08% -75.46% -19.81% -12.56% -11.44% -21.15% -18.81% -10.99% -5.62% -12.44%
Earnings before Tax (EBT) 1 5.848 11.14 -16.44 -12.95 -47.35 -16.11 -123.6 -34.63 -30.73 -31.31 -39.53 -31.9 -21.8 -15.75 -32.9
Net income 1 5.794 10.81 -14.72 -15.06 -48.97 -15.85 -123.9 -35.78 -32.96 -30 -42.72 -35.07 -21.24 -8.667 -27.31
Net margin 3.23% 5.15% -8.37% -7.52% -23.87% -7.19% -73.13% -18.26% -17.76% -15.25% -22.29% -17% -9.62% -3.44% -12.55%
EPS 2 0.0900 0.1600 -0.2300 -0.2300 -0.7600 -0.2500 -1.920 -0.5500 -0.5100 -0.4600 -0.6500 -0.5146 -0.3075 -0.1225 -0.4354
Dividend per Share 2 - - - - - - - - - - - - - - -
Announcement Date 03/11/21 22/02/22 04/05/22 03/08/22 02/11/22 22/02/23 03/05/23 03/08/23 01/11/23 21/02/24 02/05/24 - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - 108 - - - - - -
Net Cash position 1 176 - 342 - 183 145 111 96.1
Leverage (Debt/EBITDA) - 43.45 x - - - - - -
Free Cash Flow 1 22.4 -2.74 97.2 - -58.6 -24 13.3 62.5
ROE (net income / shareholders' equity) -15.2% -12.3% 3.89% -21.7% -27.1% -36.6% -20.7% -9.67%
ROA (Net income/ Total Assets) -9.3% -6.6% 1.92% -9.66% -10.2% -9.8% -5% -1.7%
Assets 1 266.2 521.3 810.8 979 2,189 1,144 1,519 2,597
Book Value Per Share 2 3.330 6.010 6.730 - 4.830 4.640 4.850 5.330
Cash Flow per Share 2 0.7200 0.4000 1.730 - -0.4900 0.7600 1.050 1.600
Capex 1 19.5 27.4 14.2 - 26.8 27.3 30.1 36.4
Capex / Sales 5.39% 5.49% 2.02% - 3.58% 3.16% 3.16% 3.49%
Announcement Date 24/02/20 24/02/21 22/02/22 22/02/23 21/02/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Tandem Diabetes Care, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
44.72 USD
Average target price
41.29 USD
Spread / Average Target
-7.68%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
TANDEM DIABETES CARE, INC. Stock Tandem Diabetes Care, Inc.
+51.18% 2.89B
ABBOTT LABORATORIES Stock Abbott Laboratories
-3.79% 184B
MEDTRONIC PLC Stock Medtronic plc
-0.84% 108B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-3.75% 67.8B
DEXCOM, INC. Stock DexCom, Inc.
+3.45% 51.05B
CENCORA, INC. Stock Cencora, Inc.
+9.04% 44.67B
HOYA CORPORATION Stock Hoya Corporation
+3.40% 41.78B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+3.21% 26.78B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
+3.66% 26.59B
TERUMO CORPORATION Stock Terumo Corporation
+15.23% 25.86B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. TNDM Stock
  4. Financials Tandem Diabetes Care, Inc.